Back to BlackRock, Inc.BBOT
BBOT3 quarters
Position history for BlackRock, Inc.'s holdings in BRIDGEBIO ONCOLOGY THERAPEUT
BlackRock, Inc. holds 2.1M shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $18.7M as of 2026-Q1. The position was increased (+0.2% shares). BBOT represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$18.7M
Current Shares
2.1M
Total Value Change
-$5M
Total Shares Change
+39,745
Quarter-by-Quarter History
Other major holders of BBOT: WELLINGTON MANAGEMENT GROUP LLP, Alphabet Inc., CITADEL ADVISORS LLC